It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Omnitrope® is indicated for
six growth-related disorders1

A young boy and his father riding bicycles on a bike trail. Both are wearing helmets and smiling.

Omnitrope is a laboratory-created human growth hormone.

It’s indicated for children with:

  • Growth failure due to growth hormone deficiency (GHD)
  • Prader-Willi syndrome
  • Small for gestational age
  • Turner syndrome
  • Idiopathic short stature

It is also indicated for adults with growth hormone deficiency.

For patient-friendly information about growth-related disorders, visit our patient site.

Formulary coverage of Omnitrope and other somatropins can vary based on indication.

The charts below outline indications for somatropins.

A young boy and a female doctor holding a notebook and wearing a stethoscope. The boy looks happy looking at the doctor.
HCP Drop bar

Compare Omnitrope Liquid Formulation to other brands

In this table, indications of the liquid formulation of Omnitrope® are compared with other somatropin brands Norditropin® (Novo Nordisk) and Nutropin AQ® (Genentech).


Compare Omnitrope Lyophilized Formulation to other brands

In this table, indications of the lyophilized formulation of Omnitrope® are compared with other somatropin brands Humatrope® (Eli Lilly), Genotropin® (Pfizer), Saizen® (EMD Serono), and Zomacton® (Ferring).


*Norditropin is also indicated for short stature associated with Noonan syndrome.2

Nutropin AQ is also indicated for growth failure secondary to chronic kidney disease.3

Humatrope and Zomacton are also indicated for short stature homeobox-containing gene (SHOX) deficiency.4

HCP Chrome Rail Thin

How is Omnitrope given?

Omnitrope is administered as a subcutaneous injection each day, or several times a week.1

Set your patients up for
a great start with OmniSource®

A young girl and a female doctor with a stethoscope around her neck and holding a notebook. Both are wearing masks. They are bumping elbows in a greeting gesture.

OmniSource is our complimentary patient support program that provides personalized support for your patients along every step of their growth journey.

Our OmniSoudrce Case Managers (OCM) provide assistance with insurance forms, answer financial questions, and provide ongoing support throughout the treatment journey.

Learn more about all the benefits your patients receive with OmniSource.

References: 1. Omnitrope [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2019. 2. Norditropin [prescribing information]. Plainsboro, NJ: Novo Nordisk Inc.; 2020. 3. Nutropin AQ [prescribing information]. South San Francisco, CA: Genentech, Inc.; 2016. 4. Humatrope [prescribing information]. Indianapolis, IN: Lilly USA, LLC; 2019. 5. Genotropin [prescribing information]. New York, NY: Pfizer Inc.; 2019. 6. Saizen [prescribing information]. Rockland, MA: EMD Serono, Inc.; 2020. 7. Zomacton [prescribing information]. Parsippany, NJ: Ferring Pharmaceuticals Inc.